NFKB1 and Parkinson disease: To further study the CDG mechanism in treating PD, we screened the key active components of CDG in treating PD utilizing network pharmacology and found that the CDG mechanism in treating PD could be closely associated with the Toll-like receptor and NF-κB pathways.